| Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure … RA de Boer, G De Keulenaer, J Bauersachs, D Brutsaert, JG Cleland, ... European journal of heart failure 21 (3), 272-285, 2019 | 251 | 2019 |
| Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages AJ Thorley, PA Ford, MA Giembycz, P Goldstraw, A Young, TD Tetley The journal of immunology 178 (1), 463-473, 2007 | 249 | 2007 |
| Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD PA Ford, AL Durham, REK Russell, F Gordon, IM Adcock, PJ Barnes Chest 137 (6), 1338-1344, 2010 | 231 | 2010 |
| Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised … TM Maher, EM van der Aar, O Van de Steen, L Allamassey, J Desrivot, ... The Lancet Respiratory Medicine 6 (8), 627-635, 2018 | 229 | 2018 |
| Epigenetics and airways disease IM Adcock, P Ford, K Ito, PJ Barnes Respiratory research 7, 1-19, 2006 | 204 | 2006 |
| Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis N Hirani, AC MacKinnon, L Nicol, P Ford, H Schambye, A Pedersen, ... European Respiratory Journal 57 (5), 2021 | 145 | 2021 |
| Steroid resistance in asthma: mechanisms and treatment options IM Adcock, PA Ford, P Bhavsar, T Ahmad, KF Chung Current allergy and asthma reports 8 (2), 171-178, 2008 | 137 | 2008 |
| An orally active galectin-3 antagonist inhibits lung adenocarcinoma growth and augments response to PD-L1 blockade L Vuong, E Kouverianou, CM Rooney, BJ McHugh, SEM Howie, ... Cancer research 79 (7), 1480-1492, 2019 | 112 | 2019 |
| Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 … TM Maher, M Kreuter, DJ Lederer, KK Brown, W Wuyts, N Verbruggen, ... BMJ open respiratory research 6 (1), e000422, 2019 | 89 | 2019 |
| Comparison of 3He and 129Xe MRI for evaluation of lung microstructure and ventilation at 1.5T NJ Stewart, HF Chan, PJC Hughes, FC Horn, G Norquay, M Rao, ... Journal of magnetic resonance imaging 48 (3), 632-642, 2018 | 81 | 2018 |
| TD139, A Novel Inhaled Galectin-3 Inhibitor for The Treatment of Idiopathic Pulmonary Fibrosis (IPF). Results from The First in (IPF) Patients Study. N Hirani, L Nicol, AC MacKinnon, P Ford, H Schambye, Pedersen, ... QJM: An International Journal of Medicine 109 (suppl_1), S16-S16, 2016 | 41 | 2016 |
| Chronic cough and Holmes-Adie syndrome PA Ford, PJ Barnes, OS Usmani The Lancet 369 (9558), 342, 2007 | 30 | 2007 |
| Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis: the ISABELA 1 and 2 randomized clinical trials TM Maher, P Ford, KK Brown, U Costabel, V Cottin, SK Danoff, ... Jama 329 (18), 1567-1578, 2023 | 28 | 2023 |
| Overcoming steroid unresponsiveness in airways disease IM Adcock, PC Chou, A Durham, P Ford Biochemical Society Transactions 37 (4), 824-829, 2009 | 24 | 2009 |
| Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD PA Kirkham, M Whiteman, PG Winyard, G Caramori, F Gordon, PA Ford, ... European Respiratory Journal 43 (5), 1504-1506, 2014 | 22 | 2014 |
| Autotaxin facilitates selective LPA receptor signaling F Salgado-Polo, R Borza, MT Matsoukas, F Marsais, C Jagerschmidt, ... Cell Chemical Biology 30 (1), 69-84. e14, 2023 | 18 | 2023 |
| Leukotriene B4 release by human lung macrophages via receptor-not voltage-operated Ca2+ channels TK Finney-Hayward, P Bahra, S Li, CT Poll, AG Nicholson, REK Russell, ... European Respiratory Journal 33 (5), 1105-1112, 2009 | 16 | 2009 |
| GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial IR Strambu, CA Seemayer, LMCA Fagard, PA Ford, TAK Van der Aa, ... European Respiratory Journal 61 (3), 2023 | 15 | 2023 |
| Managing COPD REK Russell, PA Ford, PJ Barnes, S Russell Springer Healthcare UK, 2011 | 15 | 2011 |
| Idiopathic pulmonary fibrosis: airway volume measurement identifies progressive disease on computed tomography scans T McLellan, PM George, P Ford, J De Backer, C Van Holsbeke, B Mignot, ... ERJ Open Research 6 (1), 2020 | 10 | 2020 |
